Cardiff has been recognised for its world-class research into adult acute myeloid leukaemia (AML).
Professor Alan Burnett led the UK national trials in this disease for more than 20 years, which have now become the world’s biggest trials for this cancer type.
Our scientists transformed treatment by testing a combination of chemotherapy drugs. Today, the combination of cytarabine (Ara-C) and daunorubicin is still used across the world.
The breakthroughs being made in Cardiff are only possible thanks to the generosity of Cancer Research UK supporters. With this support Cancer Research UK funds over 4,000 scientists, doctors and nurses across the UK.
More than a third of Cancer Research UK projects are funded by gifts left in Wills. Legacies breathe life into researchers’ work. They enable long-term research projects that lead to new treatments and continue to save lives for generations to come, leading us to a world where everybody can lead longer, better lives, free from the fear of cancer.
In the past 40 years, cancer survival has doubled in part thanks to Cancer Research UK’s pioneering research, funded by the generosity of their supporters. Cancer Research UK wants to accelerate progress and see 3 in 4 people surviving their cancer by 2034. They cannot achieve this mission alone and rely on their dedicated scientists, doctors and nurses, and the generosity of their supporters across the UK.
1 in 2 people will get cancer in their lifetime*. All of us can support the research that will beat it.
Pledge to leave a gift in your Will to Cancer Research UK today.
*Ahmad AS et al, British Journal of Cancer, 2015
